Search

Your search keyword '"Bartusevicius, Arnoldas"' showing total 33 results
Start Over Author "Bartusevicius, Arnoldas"
33 results on '"Bartusevicius, Arnoldas"'

3. Heterotopic Tubal Choriocarcinoma Coexistent with a Viable Intrauterine Pregnancy: A Case Report.

Author

Bartusevicius, Arnoldas, Bartuseviciene, Egle, Maseviciene, Minginte, Sukovas, Arturas, Birbalaite, Ieva, and Karpaviciute, Migle

Subjects
THROMBOSIS, CESAREAN section, FALLOPIAN tubes, PREGNANT women, ABDOMINAL pain, CHORIOCARCINOMA, ECTOPIC pregnancy, PRENATAL diagnosis
Abstract

Background and Objectives: Choriocarcinoma is an aggressive oncological disease that manifests as trophoblast tissue proliferation. The vast majority of primary lesions affect the uterus, with primarily extrauterine lesions being a rarity. Choriocarcinoma with an ongoing pregnancy is extremely rare because fetuses usually do not survive the third trimester. Case Report: We present a case of heterotopic tubal choriocarcinoma coexisting with a viable intrauterine pregnancy. A 30-year-old, 39-week pregnant woman (gravida 2, para 2) came to our hospital complaining of acute upper abdominal pain. During routine prenatal screening in the first trimester, no pathological ultrasound findings were detected. Similar abdominal pain episodes had been recorded at 18, 27, and 32 weeks of gestation, when patient was hospitalized for examination and observation, but the cause of symptoms at that time of gestation remained unclear. The patient underwent an emergency caesarean section due to severe abdominal pain and fetal compromise. She delivered a live male infant. During the surgery, around 1000 mL of blood clots were evacuated, and the excision of the right fallopian tube and masses, as well as the control of significant blood loss was performed. Postoperative serum beta-hCG was elevated to 139 482 IU/L, while imaging studies showed no metastasis. The histological examination of the excised tissue samples confirmed a diagnosis of tubal choriocarcinoma. With a FIGO score of 8, the patient received three courses of the EP/EMA regimen. After more than a year, the patient showed no radiographic signs of distant metastasis and is now in complete remission. Conclusions: This case highlights the diagnostic complexity of such extremely rare scenarios. Even though such cases are rare, it demonstrates the necessity for improved diagnostic measures to enhance patient outcomes in similar clinical situations. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Prognostic factors in patients with vulvar cancer: the VULCAN study

Author

Zapardiel, Ignacio, Iacoponi, Sara, Coronado, Pluvio J, Zalewski, Kamil, Chen, Frank, Fotopoulou, Christina, Dursun, Polat, Kotsopoulos, Ioannis C, Jach, Robert, Buda, Alessandro, Martinez-Serrano, Maria J, Grimm, Christoph, Fruscio, Robert, Garcia, Enrique, Sznurkowski, Jacek Jan, Ruiz, Cristina, Noya, Maria C, Barazi, Dib, Diez, Javier, De la Noval, Begoña Diaz, Bartusevicius, Arnoldas, De Iaco, Pierandrea, Otero, Maria, Diaz, Maria, Haidopoulos, Dimitrios, Franco, Silvia, Blecharz, Pawel, Zuñiga, Miguel A, Rubio, Patricia, Gardella, Barbara, Papatheodorou, Dimitrios C, Yildirim, Yusuf, Fargas, Francesc, and Macuks, Ronalds

Published
2020
Full Text
View/download PDF

11. Prognostic factors in patients with uterine sarcoma: the SARCUT study

Author

Zapardiel, Ignacio, primary, Gracia Segovia, Myriam, additional, Macuks, Ronalds, additional, Mancari, Rosanna, additional, Achimas-Cadariu, Patriciu, additional, Corrado, Giacomo, additional, Bartusevicius, Arnoldas, additional, Sukhin, Vladyslav, additional, Muruzabal, Juan C, additional, Coronado Martín, Pluvio J, additional, Gardella, Barbara, additional, Piek, Jurgen M, additional, Concin, Nicole, additional, Arab, Clemente, additional, Papatheodorou, Dimitrios, additional, Polterauer, Stephan, additional, Iacoponi, Sara, additional, Nieto, Teresa, additional, Lopez-Sanclemente, Martha C, additional, Trukhan, Hanna, additional, Gil, Maria M, additional, Bakinovskaya, Irina, additional, Dalamanava, Alena, additional, Cucurull, Marc, additional, Rovski, Dzmitry, additional, Baquedano, Laura, additional, Chiva, Luis, additional, Mardas, Marcin, additional, Mavrichev, Siarhei Anatolievich, additional, Klat, Jaroslav, additional, Lopez de la Manzanara, Carlos A, additional, and Yildirim, Yusuf, additional

Published
2023
Full Text
View/download PDF

18. The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study

Author

Gedgaudaite, Migle, primary, Sukovas, Arturas, additional, Paskauskas, Saulius, additional, Bartusevicius, Arnoldas, additional, Atstupenaite, Vaida, additional, Svedas, Eimantas, additional, Celiesiute, Joana, additional, Cizauskas, Arvydas, additional, Vaitkiene, Daiva, additional, and Gaurilcikas, Adrius, additional

Published
2022
Full Text
View/download PDF

22. Prognostic factors in patients with vulvar cancer: the VULCAN study

Author

Zapardiel, I, Iacoponi, S, Coronado, P, Zalewski, K, Chen, F, Fotopoulou, C, Dursun, P, Kotsopoulos, I, Jach, R, Buda, A, Martinez-Serrano, M, Grimm, C, Fruscio, R, Garcia, E, Sznurkowski, J, Ruiz, C, Noya, M, Barazi, D, Diez, J, Diaz De la Noval, B, Bartusevicius, A, De Iaco, P, Otero, M, Diaz, M, Haidopoulos, D, Franco, S, Blecharz, P, Zuñiga, M, Rubio, P, Gardella, B, Papatheodorou, D, Yildirim, Y, Fargas, F, Macuks, R, Zapardiel, Ignacio, Iacoponi, Sara, Coronado, Pluvio J, Zalewski, Kamil, Chen, Frank, Fotopoulou, Christina, Dursun, Polat, Kotsopoulos, Ioannis C, Jach, Robert, Buda, Alessandro, Martinez-Serrano, Maria J, Grimm, Christoph, Fruscio, Robert, Garcia, Enrique, Sznurkowski, Jacek Jan, Ruiz, Cristina, Noya, Maria C, Barazi, Dib, Diez, Javier, Diaz De la Noval, Begoña, Bartusevicius, Arnoldas, De Iaco, Pierandrea, Otero, Maria, Diaz, Maria, Haidopoulos, Dimitrios, Franco, Silvia, Blecharz, Pawel, Zuñiga, Miguel A, Rubio, Patricia, Gardella, Barbara, Papatheodorou, Dimitrios C, Yildirim, Yusuf, Fargas, Francesc, Macuks, Ronalds, Zapardiel, I, Iacoponi, S, Coronado, P, Zalewski, K, Chen, F, Fotopoulou, C, Dursun, P, Kotsopoulos, I, Jach, R, Buda, A, Martinez-Serrano, M, Grimm, C, Fruscio, R, Garcia, E, Sznurkowski, J, Ruiz, C, Noya, M, Barazi, D, Diez, J, Diaz De la Noval, B, Bartusevicius, A, De Iaco, P, Otero, M, Diaz, M, Haidopoulos, D, Franco, S, Blecharz, P, Zuñiga, M, Rubio, P, Gardella, B, Papatheodorou, D, Yildirim, Y, Fargas, F, Macuks, R, Zapardiel, Ignacio, Iacoponi, Sara, Coronado, Pluvio J, Zalewski, Kamil, Chen, Frank, Fotopoulou, Christina, Dursun, Polat, Kotsopoulos, Ioannis C, Jach, Robert, Buda, Alessandro, Martinez-Serrano, Maria J, Grimm, Christoph, Fruscio, Robert, Garcia, Enrique, Sznurkowski, Jacek Jan, Ruiz, Cristina, Noya, Maria C, Barazi, Dib, Diez, Javier, Diaz De la Noval, Begoña, Bartusevicius, Arnoldas, De Iaco, Pierandrea, Otero, Maria, Diaz, Maria, Haidopoulos, Dimitrios, Franco, Silvia, Blecharz, Pawel, Zuñiga, Miguel A, Rubio, Patricia, Gardella, Barbara, Papatheodorou, Dimitrios C, Yildirim, Yusuf, Fargas, Francesc, and Macuks, Ronalds

Abstract

Objective: This study aimed to analyze the prognostic factors for overall and progression-free survival in patients with vulvar cancer. Methods: This international, multicenter, retrospective study included 2453 patients diagnosed with vulvar cancer at 100 different institutions. Inclusion criteria were institutional review board approval from each collaborating center, pathologic diagnosis of invasive carcinoma of the vulva, and primary treatment performed at the participating center. Patients with intraepithelial neoplasia or primary treatment at non-participating centers were excluded. Global survival analysis and squamous cell histology subanalysis was performed. Results: After excluding patients due to incomplete data entry, 1727 patients treated for vulvar cancer between January 2001 and December 2005 were registered for analysis (1535 squamous, 42 melanomas, 38 Paget's disease and 112 other histologic types). Melanomas had the worse prognosis (p=0.02). In squamous vulvar tumors, independent factors for increase in local recurrence of vulvar cancer were: no prior radiotherapy (p<0.001) or chemotherapy (p=0.006), and for distant recurrence were the number of positive inguinal nodes (p=0.025), and not having undergone lymphadenectomy (p=0.03) or radiotherapy (p<0.001), with a HR of 1.1 (95% CI 1.2 to 1.21), 2.9 (95% CI 1.4 to 6.1), and 3.1 (95% CI 1.7 to 5.7), respectively. Number of positive nodes (p=0.008), FIGO stage (p<0.001), adjuvant chemotherapy (p=0.001), tumor resection margins (p=0.045), and stromal invasion >5 mm (p=0.001) were correlated with poor overall survival, and large case volume (≥9 vs <9 cases per year) correlated with more favorable overall survival (p=0.05). Conclusions: Advanced patient age, number of positive inguinal lymph nodes, and lack of adjuvant treatment are significantly associated with a higher risk of relapse in patients with squamous cell vulvar cancer. Case volume per treating institution, FIGO stage, and strom

Published
2020

28. Consumer assessment of health plans survey® (CAHPS®) evaluation in patients treated for endometrial cancer

Author

Aivara Urbutė, Migle Gedgaudaite, Barcaite, Egle, and Bartusevicius, Arnoldas

Subjects
618.14-006.6 [udc], Endometrial neoplasms, surgery, Health care surveys, methods, Methods
Abstract

Aims To analyse patients’ opinion about communication with a surgeon before and after the surgical treatment of endometrial cancer using the CAHPS®. Method Perspective cohort study of 57 (response rate 79.2%) patients treated for endometrial cancer in Lithuanian University of Health Sciences Hospital. The translated CAHPS® and Rosenberg Self-Esteem Scale (group A – low self-esteem, 15 points (n=47)) was used with 2 additional questions about pain. χ2 tests were made, data was considered statistically significant if p

Published
2017

33. Pelvic Floor Muscle Training With Or Without Tibial Nerve Stimulation and Lifestyle Changes Have Comparable Effects on The Overactive Bladder. A Randomized Clinical Trial.

Author

Bykoviene, Lina, Kubilius, Raimondas, Aniuliene, Rosita, Bartuseviciene, Egle, and Bartusevicius, Arnoldas

Subjects
*RANDOMIZED controlled trials, *PELVIC floor, *NEURAL stimulation, *URINARY incontinence, *QUALITY of life
Abstract

Purpose: To compare effects of transcutaneous posterior tibial nerve stimulation (TPTNS) and pelvic floor muscle training (PFMT) in women with overactive bladder syndrome (OAB). Material and Methods: We randomized 67 women ≥ 18 years with OAB to three parallel groups: group I (n = 22) received life-style recommendations (LSR) only; group II (n = 24) had LSR + PFMT and group III (n = 21) had LSR + PFMT + TPTNS. Urgency, evaluated by a 3-day voiding diary before treatment and six weeks later, was the main outcome measure. The King's College Health Questionnaire was also administered. Results: Urgency was significantly reduced in all three groups from 5.1 ± 3.7 to 3.8 ± 3.2 episodes/day, P = .016 in group I, from 5.2 ± 3.6 to 3.2 ± 2.9, P = .006 in group II and from 6.8 ± 3.1 to 4.4 ± 3.5 in group III, P = .013. There were no intergroup differences. The questionnaire results improved significantly only in group III as regards general health perception, role limitation, physical and social limitations without intergroup differences. Women improved their micturition frequency in two groups from 8.9 ± 3.2 to 7.5 ± 2.3 episodes/per day, P = .025 in group II, and from 8.8 ± 2.3 to 7.4 ± 2.0, P = .001 in group III, but only in group II was a significant reduction of urinary incontinence seen from 3.8 ± 4.6 to 2.9 ± 4.8 episodes/day, P = .045. Conclusion: All three treatments lead to effective short-term reduction of urgency in women with OAB, but longterm efficacy evaluation is required. [ABSTRACT FROM AUTHOR]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results